Businessweek Archives

Fda Overhaul Ahead?


Washington Outlook: CAPITAL WRAPUP

FDA OVERHAUL AHEAD?

Republicans and industries clamoring for regulatory easing at the Food & Drug Administration have an unexpected ally. Representative Ron Wyden (D-Ore.), a hero of consumer advocates, has embraced key changes. He favors less pre-approval product testing, fewer export restrictions on unapproved medical devices, and shifting some FDA reviews to outside testing labs. Many Democrats and consumer groups fear such moves could lessen food and medical safety.EDITED BY OWEN ULLMANN


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus